CORDARONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cordarone, and when can generic versions of Cordarone launch?
Cordarone is a drug marketed by Wyeth Pharms Inc and Wyeth Pharms and is included in two NDAs.
The generic ingredient in CORDARONE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cordarone
A generic version of CORDARONE was approved as amiodarone hydrochloride by TEVA PHARMS on November 30th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CORDARONE?
- What are the global sales for CORDARONE?
- What is Average Wholesale Price for CORDARONE?
Summary for CORDARONE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Clinical Trials: | 27 |
| Patent Applications: | 5,352 |
| DailyMed Link: | CORDARONE at DailyMed |
Recent Clinical Trials for CORDARONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| OHSU Knight Cancer Institute | Phase 2 |
| University of Calgary | Phase 4 |
| University Hospital, Caen | Phase 4 |
US Patents and Regulatory Information for CORDARONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | CORDARONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 020377-001 | Aug 3, 1995 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Pharms | CORDARONE | amiodarone hydrochloride | TABLET;ORAL | 018972-001 | Dec 24, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
